BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1776434)

  • 41. [The criteria of radiotherapy for treating carcinoma of the esophagus].
    Ikeda M; Ando N; Ishikawa T; Iwata T; Uematsu S; Egawa S; Ohkawa T; Kakegawa T; Kaneta K; Tanaka Y
    Gan No Rinsho; 1987 Aug; 33(9):1001-19. PubMed ID: 3626029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current status of preoperative treatment for carcinoma of the esophagus.
    Naunheim KS
    Semin Thorac Cardiovasc Surg; 1992 Oct; 4(4):270-5. PubMed ID: 1457565
    [No Abstract]   [Full Text] [Related]  

  • 43. [Combined therapy of cancer of the esophagus (a review of the literature)].
    Chernousov AF; Stranadko EF
    Khirurgiia (Mosk); 1973 Mar; 49(3):125-32. PubMed ID: 4754917
    [No Abstract]   [Full Text] [Related]  

  • 44. [Combined preoperative 60Co radiation and surgery for middle-third esophageal carcinoma--an analysis of 323 cases].
    Zhang YD
    Zhonghua Zhong Liu Za Zhi; 1985 May; 7(3):203-6. PubMed ID: 4017847
    [No Abstract]   [Full Text] [Related]  

  • 45. [Extrapulmonary small cell carcinoma in 52 patients].
    Yuan ZY; Guan ZZ; Zhou ZM; Xia Y; Huang WZ; Yang XL
    Ai Zheng; 2006 Sep; 25(9):1131-3. PubMed ID: 16965656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment experiences with intracavitary 137Cs after-loading in a five-year patient material with uterine-cervical carcinoma.
    Csömör S; Vigváry Z; Szanyi L
    Acta Chir Hung; 1991; 32(2):119-26. PubMed ID: 1819882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Problems and present status of clinical trials for esophageal carcinoma].
    Hayashi K; Ide H
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():348-55. PubMed ID: 7986114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical evidence of feasibility and efficacy of simultaneous irradiation and chemotherapy in advanced squamous cell carcinoma.
    John M; Flam M; Wittlinger P; Podolsky W; Padmanabhan A; Mowry PA
    Prog Clin Biol Res; 1986; 216():287-301. PubMed ID: 3088598
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
    Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Delayed radiation myelopathy].
    Haltia M; Fogelholm R; Andersson L
    Duodecim; 1974; 90(8):602-6. PubMed ID: 4409131
    [No Abstract]   [Full Text] [Related]  

  • 52. [Combined preoperative chemotherapy, hyperbaric oxygenation and radiation in advanced cancer of the esophagus].
    Sasajima K; Taniguchi Y; Morino K; Yamashita K; Onda M; Takubo K; Ebata K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1941-3. PubMed ID: 2439022
    [No Abstract]   [Full Text] [Related]  

  • 53. Radiation management in esophageal cancer. With a review of intraesophageal radioactive iridium treatment in 24 patients.
    George FW
    Am J Surg; 1980 Jun; 139(6):795-804. PubMed ID: 6770701
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapy and prognosis of hypernephroid kidney carcinoma].
    Brühl P; Scheef W; Albert H; Bücheler E
    Med Klin; 1975 May; 70(20):873-8. PubMed ID: 805904
    [No Abstract]   [Full Text] [Related]  

  • 55. [Feasibility study: concurrent 13-cis-retinoic acid, alfa-2a interferon and radiotherapy in the treatment of 23 patients with advanced cervix uteri epidermoid carcinoma].
    Paredes Espinoza M; Delgadillo Madrueño F; Paredes Casillas P; Delgadillo Hernández JJ; Ayala Castellanos MM; Alvarez Márquez V; Buenrostro Ahued MA; Arias Castro G
    Ginecol Obstet Mex; 1995 May; 63():205-9. PubMed ID: 7789851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Combined radiation and surgical treatment of cancer of the middle 1/3 of the esophagus].
    Mamontov AS
    Khirurgiia (Mosk); 1979 Jun; (6):31-8. PubMed ID: 449236
    [No Abstract]   [Full Text] [Related]  

  • 57. Esophageal pseudodiverticulum following high-dose-rate intracavitary irradiation for esophageal cancer.
    Hishikawa Y; Taniguchi M; Kamikonya N; Tanaka S; Miura T
    Radiat Med; 1988; 6(6):267-71. PubMed ID: 3150585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Postoperative adjuvant high-dose rate interstitial radiotherapy for thoracic esophageal cancer: usefulness of a latissimus dorsi muscle flap: preliminary report].
    Tsujinaka T; Shiozaki H; Murata A; Nishijima J; Inoue M; Umeshita K; Mori T
    Nihon Geka Gakkai Zasshi; 1993 Nov; 94(11):1222. PubMed ID: 8272055
    [No Abstract]   [Full Text] [Related]  

  • 59. [Radiotherapy following radical surgery--indications - technique - complications].
    Rühl U
    Z Arztl Fortbild (Jena); 1991 Nov; 85(21):1045-6. PubMed ID: 1759475
    [No Abstract]   [Full Text] [Related]  

  • 60. Histopathological evaluation of hyperthermo-chemo-radiotherapy for carcinoma of the esophagus.
    Sugimachi K; Kai H; Matsufuji H; Ueo H; Inokuchi K
    J Surg Oncol; 1986 Jun; 32(2):82-5. PubMed ID: 3724199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.